These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15351379)

  • 1. Physiological measures of therapeutic response to interferon beta-1a treatment in remitting-relapsing MS.
    White AT; Petajan JH
    Clin Neurophysiol; 2004 Oct; 115(10):2364-71. PubMed ID: 15351379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-exercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation: a study in multiple sclerosis.
    Perretti A; Balbi P; Orefice G; Trojano L; Marcantonio L; Brescia-Morra V; Ascione S; Manganelli F; Conte G; Santoro L
    Clin Neurophysiol; 2004 Sep; 115(9):2128-33. PubMed ID: 15294215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective clinical and electrophysiological follow-up on a multiple sclerosis population treated with interferon beta-1 a: a pilot study.
    Feuillet L; Pelletier J; Suchet L; Rico A; Ali Cherif A; Pouget J; Attarian S
    Mult Scler; 2007 Apr; 13(3):348-56. PubMed ID: 17439904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta].
    Pokryszko-Dragan A; Bilińska M; Gruszka E; Dubik-Jezierzańska M
    Pol Merkur Lekarski; 2005 Nov; 19(113):654-8. PubMed ID: 16498805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
    Goldman MD; Marrie RA; Cohen JA
    Mult Scler; 2008 Apr; 14(3):383-90. PubMed ID: 17942508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis.
    Portaccio E; Zipoli V; Siracusa G; Sorbi S; Amato MP
    Eur Neurol; 2008; 59(3-4):131-5. PubMed ID: 18057899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study.
    Saida T; Tashiro K; Itoyama Y; Sato T; Ohashi Y; Zhao Z;
    Neurology; 2005 Feb; 64(4):621-30. PubMed ID: 15728282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing disability progression with the Multiple Sclerosis Functional Composite.
    Rudick RA; Polman CH; Cohen JA; Walton MK; Miller AE; Confavreux C; Lublin FD; Hutchinson M; O'Connor PW; Schwid SR; Balcer LJ; Lynn F; Panzara MA; Sandrock AW
    Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
    Mezei Z; Bereczki D; Csiba L; Csépány T
    Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
    Minagar A; Alexander JS; Schwendimann RN; Kelley RE; Gonzalez-Toledo E; Jimenez JJ; Mauro L; Jy W; Smith SJ
    Arch Neurol; 2008 Feb; 65(2):199-204. PubMed ID: 18071030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with primary biliary cirrhosis do not show post-exercise depression of cortical excitability.
    Cerri G; Cocchi CA; Montagna M; Zuin M; Podda M; Cavallari P; Selmi C
    Clin Neurophysiol; 2010 Aug; 121(8):1321-8. PubMed ID: 20363183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
    Kappos L; Traboulsee A; Constantinescu C; Erälinna JP; Forrestal F; Jongen P; Pollard J; Sandberg-Wollheim M; Sindic C; Stubinski B; Uitdehaag B; Li D
    Neurology; 2006 Sep; 67(6):944-53. PubMed ID: 17000959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.
    Baum K; O'Leary C; Coret Ferrer F; Klímová E; Procházková L; Bugge J;
    Mult Scler; 2007 Nov; 13(9):1153-60. PubMed ID: 17967843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-frequency whole-body vibration on motor-evoked potentials in healthy men.
    Mileva KN; Bowtell JL; Kossev AR
    Exp Physiol; 2009 Jan; 94(1):103-16. PubMed ID: 18658234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatigue perceived by multiple sclerosis patients is associated with muscle fatigue.
    Steens A; de Vries A; Hemmen J; Heersema T; Heerings M; Maurits N; Zijdewind I
    Neurorehabil Neural Repair; 2012 Jan; 26(1):48-57. PubMed ID: 21856990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.
    Pozzilli C; Prosperini L; Sbardella E; De Giglio L; Onesti E; Tomassini V
    Neurol Sci; 2005 Dec; 26 Suppl 4():S174-8. PubMed ID: 16388353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study.
    Ghezzi A;
    Neurol Sci; 2005 Dec; 26 Suppl 4():S183-6. PubMed ID: 16388355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation.
    Caramia MD; Palmieri MG; Desiato MT; Boffa L; Galizia P; Rossini PM; Centonze D; Bernardi G
    Clin Neurophysiol; 2004 Apr; 115(4):956-65. PubMed ID: 15003779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigued patients with multiple sclerosis have impaired central muscle activation.
    Andreasen AK; Jakobsen J; Petersen T; Andersen H
    Mult Scler; 2009 Jul; 15(7):818-27. PubMed ID: 19465444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis.
    Jung P; Beyerle A; Ziemann U
    Mult Scler; 2008 May; 14(4):553-6. PubMed ID: 18562509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.